Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cytarabine

View Patient Information
An antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA. Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair.
Synonym:.beta.-Cytosine arabinoside
1-beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone
2(1H)-pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-
arabinofuranosylcytosine
arabinosylcytosine
aracytidine
beta-cytosine arabinoside
cytarabine hydrochloride
cytarabinum
cytosine arabinoside
cytosine arabinosine hydrochloride
cytosine-.beta.-arabinoside
cytosine-beta-arabinoside
tarabine PFS
Foreign brand name:Alexan
ARA-cell
Arabine
Aracytin
Aracytine
Cytarbel
Cytosar
Erpalfa
Starasid
Udicil
Abbreviation:ARA-C
Code name:CHX-3311
U 19920
U-19920
U-29920A HCl
WR-28453
Chemical structure:1-.beta.-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone
1-beta-D-arabinofuranosylcytosine
1.beta.-D-arabinofuranosylcytosine
2(1H)-pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-
4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
IND number:1714
NSC code:287459
Search NCI's Drug Dictionary